See attached. Synsorb gets a mention, along with Biomira.
Been following this one for awhile. Bought Friday.
I like these cheap biotechs that 1) have good science
and 2) are far along in trials.
And I think I may start a new thread - that "Cure For
Cancer" item doesn't quite fit.
======================
1/20/00
Paul Able, Manager of ?The Medical Fund?
Some of the small cap companies that Paul sees having strong growth potential is the Canadian firm Biomira (NASDAQ: BIOM).
Growth in the sector could be "explosive?
The Medical Fund evaluates companies using two criteria. First the company must have "compelling" science. The product or treatment
they are working to develop must have a strong scientific basis. Secondly, the company must have strong finances or alliances to allow it
to complete testing and obtain FDA approval of potential products. All have substantial potential products in the pipeline, and the ability
to move the development down the pipeline with their financial strength or alliances.
theaudioinvestor.com
1/21/00
Biomira shares surge 35%
by Leonard Zehr - Friday, January 21, 2000
Groome Capital Inc.:
Mr. Camir‚ said an unprecedented number of biotech companies are entering the last phase of clinical trials and will be launching new
products, "creating an increasing number of reasons to get back into the sector."
After biotech stocks hit rock bottom last year, "we believe the sector is due for a comeback and we have already seen early signs of this
happening," said Claude Camir‚, an analyst with Groome Capital Inc
Dlouhy Investments Inc.:
said four companies -- Hemosol, Synsorb, Biomira and AnorMed Inc. of Langley, B.C. -- are currently in Phase III clinical trials,. "A
large portion of the risk in biotech is removed after Phase II results," he said. "Yet these companies don't seem to get the recognition in
the market until after Phase III." Edmonton-based Biomira currently is conducting a major Phase III clinical trial for its Theratope breast
cancer vaccine and a Phase II trial for a lung cancer vaccine, BLP-25. |
